La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Spenda Bilan de santé

Santé financière contrôle des critères 5/6

Spenda possède un total de capitaux propres de A$33.5M et une dette totale de A$13.1M, ce qui porte son ratio d'endettement à 39%. Son actif total et son passif total sont A$50.8M et de A$17.3M.

Informations clés

39.0%

Ratio d'endettement

AU$13.05m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	AU$6.02m
Fonds propres	AU$33.51m
Total du passif	AU$17.29m
Total des actifs	AU$50.80m

Mises à jour récentes de la santé financière

Recent updates

Here's Why Spenda (ASX:SPX) Can Manage Its Debt Despite Losing Money

Apr 12

Spenda (ASX:SPX) Is Using Debt Safely

Dec 02

Is Spenda (ASX:SPX) A Risky Investment?

Jun 20

Is Spenda (ASX:SPX) Using Too Much Debt?

Mar 03

A Look At Cirralto's (ASX:CRO) CEO Remuneration

Mar 01

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de SPX ( A$20.1M ) dépassent ses passifs à court terme ( A$3.7M ).

Passif à long terme: Les actifs à court terme de SPX ( A$20.1M ) dépassent ses passifs à long terme ( A$13.6M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de SPX ( 21% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de SPX est passé de 0% à 39% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: SPX dispose d'une piste de trésorerie suffisante pour 10 mois sur la base du dernier flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Prévisions de trésorerie: SPX devrait disposer d'une marge de trésorerie suffisante pour 10 mois sur la base des estimations de flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Spenda Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Here's Why Spenda (ASX:SPX) Can Manage Its Debt Despite Losing Money

Spenda (ASX:SPX) Is Using Debt Safely

Is Spenda (ASX:SPX) A Risky Investment?

Is Spenda (ASX:SPX) Using Too Much Debt?

Recent updates

Spenda Limited (ASX:SPX) entered into binding term sheet to acquire Limepay Pty Ltd for AUD 6.65 million.

Spenda Limited Announces Appointment of Andrew Kearnan as A Non-Executive Director

New major risk - Share price stability

Spenda Limited has completed a Follow-on Equity Offering in the amount of AUD 7.175 million.

Spenda Limited Appoints David Laird as Non-Executive and Independent Director

Spenda Limited Appoints David Laird as Non-Executive and Independent Director

Spenda Limited Launches PayFac Services

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.016 loss in FY 2022)

New minor risk - Financial data availability

Here's Why Spenda (ASX:SPX) Can Manage Its Debt Despite Losing Money

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Spenda (ASX:SPX) Is Using Debt Safely

Less than half of directors are independent

Spenda Limited, Annual General Meeting, Nov 25, 2022

Spenda Limited, Annual General Meeting, Nov 25, 2022

Spenda Limited(ASX:SPX) dropped from S&P/ASX Emerging Companies Index

Full year 2022 earnings released: AU$0.016 loss per share (vs AU$0.006 loss in FY 2021)

Is Spenda (ASX:SPX) A Risky Investment?

Less than half of directors are independent

Is Spenda (ASX:SPX) Using Too Much Debt?

MD & Executive Director exercised options to buy AU$367k worth of stock.

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.01 loss in FY 2020)

Cirralto Limited completed the acquisition of Invigo Pty Ltd.

Cirralto Limited (ASX:CRO) agreed to acquire Invigo Pty Ltd for AUD 7 million.

Cirralto Limited (ASX:CRO) completed the acquisition of Appstablishment Software Group Pty Ltd from Rare Air Nominees Pty Ltd.

Independent Chairman exercised options and sold AU$213k worth of stock

A Look At Cirralto's (ASX:CRO) CEO Remuneration

Cirralto Limited Announces Software Release & BPSP/BPA Testing Update

MD & Executive Director exercised options to buy AU$390k worth of stock.

MD & Executive Director recently sold AU$423k worth of stock

Cirralto Limited, Annual General Meeting, Jan 28, 2021

Cirralto Signs BPA Agreement with Fiserv & Mastercard Extending the Company's Business Payments Services

Cirralto Limited Announces the Appointment of Richard Jarvis as Chief Financial Officer, Effective from 1 November 2020

Full year earnings released - AU$0.01 loss per share

Cirralto Limited has completed a Derivatives Offering in the amount of AUD 0.273172 million.

Full year earnings released - AU$0.0048 loss per share

Cirralto Limited announced that it expects to receive AUD 2.712 million in funding

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines